Literature DB >> 19305503

Comparison of gene expression profile in embryonic mesencephalon and neuronal primary cultures.

Dario Greco1, Floriana Volpicelli, Antonio Di Lieto, Damiana Leo, Carla Perrone-Capano, Petri Auvinen, Umberto di Porzio.   

Abstract

In the mammalian central nervous system (CNS) an important contingent of dopaminergic neurons are localized in the substantia nigra and in the ventral tegmental area of the ventral midbrain. They constitute an anatomically and functionally heterogeneous group of cells involved in a variety of regulatory mechanisms, from locomotion to emotional/motivational behavior. Midbrain dopaminergic neuron (mDA) primary cultures represent a useful tool to study molecular mechanisms involved in their development and maintenance. Considerable information has been gathered on the mDA neurons development and maturation in vivo, as well as on the molecular features of mDA primary cultures. Here we investigated in detail the gene expression differences between the tissue of origin and ventral midbrain primary cultures enriched in mDA neurons, using microarray technique. We integrated the results based on different re-annotations of the microarray probes. By using knowledge-based gene network techniques and promoter sequence analysis, we also uncovered mechanisms that might regulate the expression of CNS genes involved in the definition of the identity of specific cell types in the ventral midbrain. We integrate bioinformatics and functional genomics, together with developmental neurobiology. Moreover, we propose guidelines for the computational analysis of microarray gene expression data. Our findings help to clarify some molecular aspects of the development and differentiation of DA neurons within the midbrain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19305503      PMCID: PMC2654915          DOI: 10.1371/journal.pone.0004977

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

In the mammalian brain, dopaminergic (DA) neurons are mainly located in the ventral midbrain (mesencephalon, Mes) in which they are arranged in three distinct nuclei: substantia nigra (SN, A10), the ventral tegmental area (VTA, A9) and the retrorubral formation (A8). Neurons originating in the SN project abundantly to the dorsolateral striatum, forming the nigrostriatal pathway. DA neurons of the VTA project mainly to the ventromedial striatum, nucleus accumbens and frontal lobe, forming the mesocorticolimbic pathway. Although midbrain dopamine neurons (mDA) are relatively few (20000–40000 in the rodent), they play an important role in regulating several aspects of basic brain function. Alterations of development or survival, or impairment in DA signalling are involved in a variety of behavioural, movement, and psychiatric disorders. Specifically, nigrostriatal pathway has been implicated in Parkinson disease [1] and Huntington disease [2], as well as in drug abuse toxicity [3]. Instead, alterations in VTA outputs are involved in schizophrenia[4], depression [5], attention deficit hyperactive disorder [6] and addiction [7]. Analyses of mouse mutants defective in mDA development have highlighted several transcription factors contributing the specification of the neurotransmitter identity [8]–[10], as well as neuronal identity and maintenance [11], [12]. The molecular environment surrounding the mDA neurons plays an important role for their differentiation. Cooperative signalling by Sonic Hedgehog (SHH) from the floor plate and fibroblast growth factor (FGF) 8 from the isthmus induces mDA [13]–[16]. The mDA neuronal primary cultures represent a valuable tool to investigate the molecular mechanisms involved in the development and maintenance of these neurons. The expanded mDA cultures are generated from E11.5 rat ventral Mes, when a large number of mDA precursors are present [17]. Previously, we have demonstrated that the addition of the FGF 2 (also known as basic FGF) from the beginning of the culture in serum-free medium induces neuroblasts proliferation [18], [19]. Furthermore mDA differentiation is increased in the culture treated with SHH and FGF8. As in vivo, also in vitro these factors are the inductive signals that specify mDA phenotype [14], [19], [20]. Markers of differentiated mDA neurons are observed in primary cultures when FGF2, SHH and FGF8 are withdrawn after six days in vitro (DIV) and ascorbic acid is added. Particularly, TH immunostainings show a high number of mDA neurons. In fact at this time in vitro, the number of TH+ cells is increased about 20 folds when compared to 3 DIV cultures [19] and comparable to the number of mDA neurons present in primary cultures with or without serum plated at a 20-fold higher cell concentration [21], [22]. These expanded cultures also show the presence of both neuroblasts, as shown by nestin-immunoreactivity, as well as more mature neurons. At least 90% of the expanded cells are nestin-positive, and at least 70% are medium neurofilament-positive (NFM). Thus there is a co-localization of nestin and NFM in at least 30% of the cells. Cells expressing glial markers, such as the glial fibrillary acid protein (GFAP), are extremely rare (on average one or two GFAP-positive cells/well at 9 DIV) [19], [23]. Glutamatergic and GABAergic neurons are also present, as indicated by the levels of the glutamic acid decarboxylases (GAD65, GAD67 and EP10) and glutamate transporter (EAAT1) mRNAs. Instead serotonergic and noradrenergic neurons are absent, as indicated by lack of 5HT (serotonine transporter, SERT and tryptophan hydroxylase, TrpH) and NE (noradrenaline transporter, NET) markers, respectively [23]. In these cultures, mDA neurons are well differentiated since all molecular mDA markers, such as tyrosine hydroxilase (TH), (Dat), Nr4a2 (also known as Nurr1), and vesicular monoamine transporter 2 (Vmat-2), tyrosine kinase receptor Ret (Ret), GDNF family receptor alpha 1–2 (GFRalpha 1–2) are expressed [17]. Moreover, they also show mature functional signature since high affinity uptake, a marker of mature DA function, is present at 9 DIV. The latter is specific since it is blocked in the presence of selective dopamine uptake inhibitors but not by serotonergic and noradrenergic uptake inhibitors [23]. However, there is a lack of general picture concerning the global gene expression program of these cultures as compared to the tissue of origin. We have carried out extensive gene expression survey of rat E11.5 mesencephalon (MesE11) and Mes primary culturesPC (MesPC) at 9 DIV generated from it. For this, a microarray experiment using the Affymetrix GeneChips RAE230A has been carried out. Because of the inaccuracies in the original annotation, we have performed the computational analysis by re-annotating all the probes present on the RAE230A chipset according to three major sequence databases, such as Entrez Gene [24], RefSeq [25], and Ensembl gene [26]. The results have been then combined in order to create a robust set of result for further analysis. Finally, by using computational techniques of gene networks and promoter sequence analysis, we have uncovered possible regulatory modules responsible for the expression of multiple genes both in MesE11 and MesPC.

Results

In order to characterize the expanded mesencephalic neuronal primary cultures and their expression profiling, as well as to identify new genes involved in mDA neurons differentiation and maturation, we performed the microarray analysis. To fulfill our aim we used three independent re-annotation systems based on the alignment of each oligonucleotide probe present on the RAE230A chipset against the Entrez Gene (EG), RefSeq (RS), and Ensembl gene (ENS) databases. Based on the new identities for probes we performed three independent analyses abbreviated from now on as EG, RS, and ENS. According to the original annotation released by the manufacturer, the RAE230A chipset contains 15923 probe sets; after re-annotation the probes were re-arranged in 8676 (EG), 13224 (RS), and 7600 (ENS) probe sets. After moderated t-test, we obtained 1016 genes in EG (11.7% of all the screened genes), 1568 (9.8% of all the screened genes) genes in RS, and 862 (11.3% of all the screened genes) genes in ENS to be differentially expressed between MesE11 and MesPC with p-value<0.001 (Table 1). We annotated the gene lists using DAVID which is a gene-centered database where gene entities from several databases are uniquely stored [27]. We took advantage of this system for parsing the gene lists from the three analyses. As many as 987 genes from EG, 1038 genes in RS, and 567 genes in ENS respectively had a reliable DAVID identifier. Of these, 425 unique genes were shared between the three annotations (Figure 1). The RefSeq-based set showed the largest overlapping with the other two annotation systems. From the set of 425 common genes, 268 genes were upregulated in MesPC, and 157 were upregulated in MesE11 (Table S1). Functional classification of these groups of genes was carried out with the DAVID-based Fisher's exact test. Overall, the three annotations produced very consistent fold change estimation for all of the 425 common genes (average standard deviation = 0.04).
Table 1

Summary of the statistical analysis.

EGRSENS
Total genes analyzed (a)8676132247600
Significant genes (% of tot) (b)1016 (11.7%)1568 (9.8%)862 (11.3%)
Significant genes with annotation (% of tot significant) (c)987 (97%)1038 (66.2%)567 (65.7%)

In the columns are shown the three re-annotations used for analyzing the dataset (Entrez Gene (EG), RefSeq (RS), and Ensembl gene (ENS)). The absolute number of genes analyzed (a), found significant (b), and with an annotation in DAVID database (c) is shown. In parenthesis, the percent of all the genes analyzed is also shown.

Figure 1

Significant genes with an annotation in DAVID database.

The numbers of significant genes with a reliable DAVID annotation in each re-annotation analysis are shown. The intersections show the amount of common genes between two or all the three analyses. Proportional-area Venn diagrams were built as suggested by Chow and Rodgers [55].

Significant genes with an annotation in DAVID database.

The numbers of significant genes with a reliable DAVID annotation in each re-annotation analysis are shown. The intersections show the amount of common genes between two or all the three analyses. Proportional-area Venn diagrams were built as suggested by Chow and Rodgers [55]. In the columns are shown the three re-annotations used for analyzing the dataset (Entrez Gene (EG), RefSeq (RS), and Ensembl gene (ENS)). The absolute number of genes analyzed (a), found significant (b), and with an annotation in DAVID database (c) is shown. In parenthesis, the percent of all the genes analyzed is also shown.

Genes upregulated in midbrain neuronal expanded cultures

Five functional categories were dominating among the 268 genes over-expressed in MesPC: developmental process (95 genes), lipid metabolic process (34 genes), mitochondrion (29 genes), extracellular matrix (22 genes), and lysosome (15 genes). Additionally, neurogenesis (16 genes) and neuron differentiation (14 genes) were also significantly over-represented. Interestingly, 10 genes coding for collagens were among this group of genes with high fold change (Table S2). Microarrays are capable to observe changes in the expression of transcripts providing no explanation on how this is modulated within the cells. Gene transcription is also regulated by proteins that recognize short DNA sequence motifs, called transcription factor binding sites (TFBSs). TFBSs are in most cases located in the promoter regions of the genes. Similar TFBSs patterns within the promoters of transcripts are expressed in the same tissue under similar conditions. Thus, the organization of promoter motifs represents a framework of the regulatory mechanisms in a specific biological context. The smallest entities on the level of TFBSs combinations are called promoter modules. These are defined as two or more individual elements that act coordinately and are similarly arranged in the promoters of co-regulated transcripts. We investigated the interactions of the MesPC genes based on the PubMed co-citation and the presence of TFBS in their promoter sequences. From this analysis, a number of genes emerged to have a specific consensus binding sequence for EGR1 transcription factor in their promoters (PCR validation of the microarray results shown in Figure S1). By multiple alignments, we found a conserved module constituted by a binding site for EGR1 and a second site for SP1 (Figure 2). Next, we searched for this module in the whole set of known promoter sequences in Rattus norvegicus, locating it in the promoters of 659 genes. Geneontology classification showed significant over-representation of such families as neuron differentiation (34 genes), neurogenesis (37 genes), and neuron development (26 genes), suggesting a central role of EGR1-SP1 module during production and differentiation of neurons (Table S3).
Figure 2

Knowledge-based gene network of the MesPC-specific genes.

The nodes represent the genes. In BLUE, the MesPC-upregulated genes; in WHITE, the transcription factors not included in the list of significant genes that interact with the MesPC specific genes. The BLACK edges indicate co-citation of two genes in the PubMed database; the GREEN edges indicate the presence of a significant TFBS on the promoter of the given gene for the specific interacting transcription factor. Lower-right corner: summary of the regulatory model possibly regulating the expression of MesPC genes. The matrix elements present in the model (V$EGRF and V$SP1F), the DNA strand where they are present on the promoter regions, their relative distance, and the p-value are shown.

Knowledge-based gene network of the MesPC-specific genes.

The nodes represent the genes. In BLUE, the MesPC-upregulated genes; in WHITE, the transcription factors not included in the list of significant genes that interact with the MesPC specific genes. The BLACK edges indicate co-citation of two genes in the PubMed database; the GREEN edges indicate the presence of a significant TFBS on the promoter of the given gene for the specific interacting transcription factor. Lower-right corner: summary of the regulatory model possibly regulating the expression of MesPC genes. The matrix elements present in the model (V$EGRF and V$SP1F), the DNA strand where they are present on the promoter regions, their relative distance, and the p-value are shown.

Genes upregulated in mesencephalon at E11

We found 157 genes to be significantly over-expressed in MesE11 as compared to MesPC. These genes covered a variety of cellular and molecular functions, such as developmental process (43 genes), synaptic transmission (17 genes), nervous system development (16 genes) and neurogenesis (9 genes), and ion channels (9 genes). Interestingly, genes involved in oxygen transport (5 genes) and iron binding (11 genes) were also in this group (Table S4). As for the MesPC genes, we have inferred MesE11 gene network based on the PubMed co-citation and the presence of TFBS in their promoter sequences. This revealed a possible role for members of transcription factors of the NEUR and NR2F families in regulating the expression of many genes upregulated in MesE11. Particularly, the genes encoding respectively Neurod3 (NEUR family) and Nr2f2 (NR2F family) were significantly over-expressed in MesE11 (Figure 3). We also scanned the whole set of known Rattus norvegicus regulatory sequences, finding 726 promoters with the NEUR-NR2F module. Genes of the dopamine metabolism (Cyp2d22, Tgfb2, Nr4a2, Sncaip_predicted, Th, PCR validation of the microarray results for Nr4A2 and Th shown in Figure S1), synaptic transmission (30 genes) and development (24 genes) emerged as possible targets of NEUR-NR2F (Table S5).
Figure 3

Knowledge-based gene network of the MesE11-specific genes.

The nodes represent the genes. In BLUE, the MesE11-upregulated genes. The BLACK edges indicate co-citation of two genes in the PubMed database; the GREEN edges indicate the presence of a significant TFBS on the promoter of the given gene for the specific interacting transcription factor. Lower-right corner: summary of the regulatory model possibly regulating the expression of MesE11 genes. The matrix elements present in the model (V$NEUR and V$NR2F), the DNA strand where they are present on the promoter regions, their relative distance, and the p-value are shown.

Knowledge-based gene network of the MesE11-specific genes.

The nodes represent the genes. In BLUE, the MesE11-upregulated genes. The BLACK edges indicate co-citation of two genes in the PubMed database; the GREEN edges indicate the presence of a significant TFBS on the promoter of the given gene for the specific interacting transcription factor. Lower-right corner: summary of the regulatory model possibly regulating the expression of MesE11 genes. The matrix elements present in the model (V$NEUR and V$NR2F), the DNA strand where they are present on the promoter regions, their relative distance, and the p-value are shown.

Dopamine-related genes

The Genomatix software Bibliosphere allows to search for genes that are co-cited in the PubMed abstracts with biological themes. By this approach, we have created a catalog of 1339 Rattus Norvegicus genes related in literature to dopamine. Of these, 1032 were present on the re-annotated Affymetrix chipset 230A. A total of 84 genes were found differentially expressed in all the three datasets (Table 2), when comparing MesPC (46 genes) and MesE11 (38 genes). Interestingly, 18 dopamine-related genes over-expressed in MesPC are described as involved in cell differentiation; a subgroup of this, composed of 8 genes, is involved in neuron differentiation. Five dopamine-related MesPC genes are also associated with neurodegenerative diseases. The dopamine-related genes over-expressed in MesE11 better resampled neurophysiologic events, as they were found associated to synaptic transmission (9 genes), transmission of nerve impulse (9 genes), and behavior (7 genes). Further, we have tested the hypothesis that the transcriptional models inferred from the MesPC and MesE11 gene networks would have a potential role in the regulation of some dopamine-related genes inferred from the literature scan. This seems to be the case, as 283 (∼21%) dopamine-related genes presented the EGFR-SP1F module in their promoter regions. This group was enriched in genes involved in neuron differentiation. Similarly, the promoters of 132 (∼10%) dopamine-related genes showed the ability to bind the NEUR-NR2F module. This group was enriched in genes involved in neurophysiologic processes, such as transmission of nerve impulse and synaptic transmission.
Table 2

Dopamine-related genes found significant comparing MesPC versus MesE11.

EGIDENSIDRSIDGENESYMBOLAvgLogFCAvgAdjPvalueRelative Over-expression
24772ENSRNOG00000013589NM_022177CXCL123.103.186E-07MesPC
24153ENSRNOG00000028896NM_012488A2M2.306.543E-05MesPC
25692ENSRNOG00000019018NM_013151PLAT2.132.730E-07MesPC
24596ENSRNOG00000005392NM_012610NGFR2.066.497E-07MesPC
171163ENSRNOG00000012876NM_133623SLC6A132.059.467E-07MesPC
25625ENSRNOG00000031312NM_013091TNFRSF1A1.945.763E-05MesPC
29539ENSRNOG00000001344NM_032416ALDH21.821.480E-07MesPC
64513ENSRNOG00000005917NM_033485PAWR1.775.590E-05MesPC
83619ENSRNOG00000001548NM_031789NFE2L21.771.405E-04MesPC
54702ENSRNOG00000005053NM_019371EGLN31.742.600E-06MesPC
117549ENSRNOG00000002524NM_057201GPR371.655.267E-06MesPC
24212ENSRNOG00000007290NM_012505ATP1A21.643.262E-04MesPC
24423ENSRNOG00000029726NM_017014GSTM11.583.070E-06MesPC
315714ENSRNOG00000008680NM_001012125LOXL11.522.213E-06MesPC
316742ENSRNOG00000015906NM_001015020TGIF1.504.307E-05MesPC
29318ENSRNOG00000001239NM_024131DDT1.469.887E-06MesPC
25728ENSRNOG00000018454NM_138828APOE1.453.105E-04MesPC
24223ENSRNOG00000017123NM_012512B2M1.402.920E-06MesPC
295217ENSRNOG00000013356NM_001025648SNAPAP1.181.663E-06MesPC
85272ENSRNOG00000007108XM_342591BMP71.161.742E-04MesPC
81818ENSRNOG00000018087NM_031140VIM1.154.160E-06MesPC
81632ENSRNOG00000002636NM_031003ABAT1.104.378E-04MesPC
25112ENSRNOG00000005615NM_024127GADD45A1.099.963E-06MesPC
25104ENSRNOG00000019372NM_012744PC1.021.747E-04MesPC
25227ENSRNOG00000011150NM_033443ARSB1.013.541E-04MesPC
24392ENSRNOG00000000805NM_012567GJA11.002.673E-04MesPC
25177ENSRNOG00000000875NM_001033926FHL10.933.247E-05MesPC
25491ENSRNOG00000018681NM_012987NES0.904.750E-04MesPC
83584ENSRNOG00000009508NM_031775CASP60.902.798E-04MesPC
24686ENSRNOG00000021259NM_012631PRNP0.901.443E-05MesPC
25508ENSRNOG00000033280NM_013000PAM0.844.407E-06MesPC
363875ENSRNOG00000001068NM_134366RAC10.836.853E-05MesPC
24530ENSRNOG00000019573NM_017024LCAT0.813.600E-05MesPC
50719ENSRNOG00000018824NM_017353SLC7A50.791.085E-04MesPC
24788ENSRNOG00000017291NM_017052SORD0.799.679E-05MesPC
79212ENSRNOG00000006527NM_024371SLC6A10.798.860E-06MesPC
84485ENSRNOG00000019691NM_053425CCS0.782.463E-04MesPC
286898ENSRNOG00000012062NM_173118NPC20.727.973E-06MesPC
25125ENSRNOG00000019742NM_012747STAT30.716.022E-04MesPC
25368ENSRNOG00000012325NM_012895ADK0.622.013E-04MesPC
171135ENSRNOG00000014475NM_133600SLC31A10.623.827E-04MesPC
299858ENSRNOG00000025053XM_243524LRP10.572.421E-04MesPC
83799ENSRNOG00000012640NM_031973DPP70.573.506E-04MesPC
29499ENSRNOG00000006120NM_017221SHH0.471.974E-04MesPC
24786ENSRNOG00000002115NM_017050SOD10.448.478E-04MesPC
24644ENSRNOG00000002467NM_053291PGK10.396.110E-04MesPC
112400ENSRNOG00000010392NM_031588NRG1−0.337.169E-04MesE11
24807ENSRNOG00000005853NM_012667TACR1−0.353.776E-04MesE11
24600ENSRNOG00000009348NM_021838NOS3−0.432.880E-04MesE11
114856ENSRNOG00000003977NM_053769DUSP1−0.433.614E-04MesE11
171099ENSRNOG00000014761NM_133568RASD2−0.445.449E-04MesE11
192215ENSRNOG00000028844NM_138858SLC9A5−0.445.824E-04MesE11
29410ENSRNOG00000022405NM_019207NEUROD3−0.481.579E-04MesE11
113912ENSRNOG00000030920NM_053613RTN4R−0.511.507E-04MesE11
29427ENSRNOG00000000853NM_017196AIF1−0.514.323E-05MesE11
54305ENSRNOG00000002793NM_019348SSTR2−0.534.593E-04MesE11
25033ENSRNOG00000022714NM_012719SSTR1−0.695.147E-05MesE11
116669ENSRNOG00000019689XM_342759VWF−0.732.187E-05MesE11
24832ENSRNOG00000006604NM_012673THY1−0.753.745E-04MesE11
117059ENSRNOG00000016977NM_053988CALB2−0.763.637E-05MesE11
54705ENSRNOG00000016180NM_019372PPM2C−0.798.380E-04MesE11
300519ENSRNOG00000033217NM_001004245ESAM−0.792.047E-04MesE11
25017ENSRNOG00000022968NM_022178MYO5A−0.801.551E-04MesE11
24318ENSRNOG00000008428NM_012547DRD2−0.812.270E-05MesE11
81718ENSRNOG00000000158NM_052809CDO1−0.905.650E-05MesE11
24626ENSRNOG00000005905NM_017031PDE4B−0.925.956E-04MesE11
25256ENSRNOG00000034191NM_012792FMO1−0.921.957E-05MesE11
24778ENSRNOG00000007284NM_138827SLC2A1−0.942.427E-05MesE11
29700ENSRNOG00000000566NM_001007601PCBD1−1.024.220E-06MesE11
360918ENSRNOG00000028015NM_001007729CXCL4−1.055.917E-06MesE11
25550ENSRNOG00000014816NM_013032SLC1A1−1.075.360E-04MesE11
171128ENSRNOG00000012290NM_133595GCHFR−1.137.110E-05MesE11
54294ENSRNOG00000002730NM_019341RGS5−1.172.654E-04MesE11
63885ENSRNOG00000011310NM_022236PDE10A−1.244.630E-04MesE11
25549ENSRNOG00000008890NM_013031SLC18A2−1.298.150E-06MesE11
25361ENSRNOG00000014333NM_012889VCAM1−1.334.330E-06MesE11
54278ENSRNOG00000005600NM_019328NR4A2−1.383.559E-04MesE11
24688ENSRNOG00000015643NM_012633PRPH1−1.511.306E-05MesE11
24806ENSRNOG00000007374NM_012666TAC1−2.021.387E-06MesE11
24588ENSRNOG00000013916NM_017029NEF3−2.112.025E-04MesE11
84487ENSRNOG00000016147NM_053427SLC17A6−2.123.212E-04MesE11
25085ENSRNOG00000020410NM_012740TH−3.012.853E-07MesE11
24797ENSRNOG00000001837NM_012659SST−3.123.522E-07MesE11
24440ENSRNOG00000033465NM_033234HBB−6.417.133E-10MesE11

Discussion

Model organisms are widely used in biomedical research elucidating mechanisms which would be impossible to experiment on using human samples. Mice and rats are often regarded as optimal choices for working on the mammalian CNS. However, Rattus norvegicus genome has been annotated much less in detail, as compared to the Mus musculus genome. In this paper we utilized up-to-date methods for annotating rat arrays with the best possible accuracy. We have used the transcriptional profiling for comparing tissue samples from rat brain to primary cells from the same origin. We studied the effect of re-annotation and at the same time elucidated how well primary cells resemble the original tissues in the level of transcriptional profile. We have extensively investigated the gene expression in rodents' mesencephalon at E11.5 and neuronal primary cultures after 9 DIV, derived from it. For this, we have carried out a microarray experiment using the Affymetrix GeneChips RAE230A for the Rattus norvegicus genome. Because of the design inaccuracies and of the fast speed of updating information concerning the genes and transcripts sequences, many Affymetrix probes are known to have severe design problems as such. Particularly for the chipset RAE230A, several probe sets contain probes with multiple genome hits (13.2%), with no known target (3.6%), with allele-specific probes (19.5%) [28]. Currently, several re-annotation methods are available allowing the probes to be mapped to genes, transcripts, or even exons sequences stored in public databases. However, exon-based re-annotation leads to decreased precision and increased variance in estimating gene expression, probably due to the smaller number of probes that map to each exon [29]. Moreover, due to the fact that the majority of the probes are designed ignoring splicing variances, we find more convenient to work with gene-based rather than transcript-based re-annotations. During the re-annotation process, each single oligonucleotide probe is re-assigned to the correct gene. However, some probes are eliminated, because they don't reliably recognize any transcript, they have been designed for matching the antisense sequence of a given transcript, or they are designed in allele-specific regions. For instance, only the 53.6% (EG), 60.5% (RF), and 44% (ES) of all the RAE230A probes can be utilized for re-annotation. Long lists of differentially expressed candidate genes are usually produced from microarray analysis. However, they cannot be considered as the end point of the analysis but rather as the starting point of a more meaningful interpretation, by taking advantage of the increasing knowledge about the functions of the genes within the cells. The annotation of the genes or transcripts is usually obtained from public libraries such as Gene Ontology [30] or KEGG [31]. Similarly, one can test whether the expression of genes located in specific portions of chromatin (i.e. cytobands or entire chromosome) are involved in certain experimental conditions. For any of the annotations used for grouping the genes, the terms are defined a priori and constructed independently from the experimental data. The DAVID database is one of the most reliable tools for annotating genes and transcripts, as well as for finding over-represented functional groups of genes in a given gene list. Interestingly, as many as 97% of all the significant EG entities were mapped into DAVID, while only 66.2% and 65.7% respectively from the RS and ENS presented a reliable DAVID annotation. Therefore, we conclude that the re-annotation of the Affymetrix probes according to the Entrez Gene database is the best in terms of gene annotation and functional analysis. Similar results were observed also during the re-annotation of the Affymetrix probes for human genes [32], [33]. Investigating gene expression by microarrays presents some limitations especially related to the fact that microarrays can estimate only the levels of the transcripts within the cells, not giving any information concerning the post-transcriptional regulations. In addition, only rigorous statistical methods allow keeping the false discovery rates at reasonable levels, as many technical sources of variations can affect the measurements. Other restrictions to be considered when working with large-scale gene expression studies consist in the inaccuracy of the functional annotation of some genes: for instance, many genes are annotated in the ontology “apoptosis”, without being directly correlated to this specific process, but simply being involved more generally in cell homeostasis. Careful inspection is always needed for a correct interpretation of long gene lists resulting from microarray assays. Finally, microarrays detect transcripts at very low concentrations, but when working with complex tissues, such as the brain, assigning the expression patterns to a certain cellular subpopulation is impossible. Nevertheless, we believe that the tissues should always be intended as functional entities and their global gene expression should be target of interest. When examining whole tissues, gene expression from a variety of cell types, including non-neuronal tissues (especially blood), is recorded. This explains why we observed gene groups of haemoglobins and oxygen transport as significantly over-represented in MesE11 over MesPC. Overall, our results suggest that the MesPC are a reliable tool to be used in developmental neurobiology, as their gene expression programs largely resemble the tissue of origin. As these cell cultures comprise a mixed cell population, they are used by the scientific community because they mirror the midbrain neuronal composition better than more homogeneous cell lines [19], [23]. Thus we believe that it is important to know what the gene expression profiles are in these cultures. We found genes of the extracellular matrix and of the focal adhesions to be upregulated in MesPC. In the mesencephalon, the adhesion structures are synthesized and maintained by glial cells, that are absent in primary cultures. The protocol used to establish midbrain neuronal cultures enhances dopaminergic differentiation, thus leading to enrichment in positive neurons, when compared to standard cultures [34]. However, some genes of the dopamine biosynthesis were found over-expressed in MesE11. This finding is consistent with the decrease of TH mRNA observed during the in vitro culture progression [19], [23], [34], and can be due to the decrease of trans-synaptic stimulation following the dissociation of the tissue. We identified Egr1 and Sp1 as key elements in the regulation of the transcription patterns in MesPC. Particularly, early growth response genes encode for transcription factors that regulate gene expression in response to a variety of stimuli influencing cell growth and differentiation, as well as response to injury and reaction to chronic nervous system diseases [35]. Following depolarization, transcription of the Egr1 gene increases in the MesPC [36], suggesting that this immediate early transcription factor might be a key gene mediating the electrical activity leading to neuronal differentiation. Mice lacking EGR genes present a wide range of developmental abnormalities, including infertility [37], defects of the hindbrain morphogenesis [38], defective myelination in the peripheral nervous system [39], and defects in learning and memory [40], [41]. Gene network and promoter alignment techniques suggested that several key transcripts found in MesE11 can be regulated by the binding of transcription factors of the NEUR and NR2F families. Moreover, the levels of Neurod3 (NEUR) and Nr2f2 (NR2F) were found over-expressed in MesE11. Neurogenic basic helix-loop-helix (bHLH) factors Mash1, neurogenins (Ngns) and NeuroD3 (also known as Ngn1) play important roles in Nurr1-induced mDA neuronal differentiation [42]. While the role of Ngn2 in the development of mDA neurons is well known [43], [44], less information is available concerning Neurod3. In addition to inducing neurogenesis by functioning as a transcriptional activator, Neurod3 seems to inhibit the differentiation of neural stem cells into astrocytes [45]. COUP-TFII (Nr2f2) seems to be involved in tangential GABAergic interneurons migration in the developing brain, through the regulation of short- and long-range guidance cues [46]. Functions of Nr2f2 in the mDA phenotype definition are still to be described. In summary, we present a broad view of the transcriptome of the DA neurons in primary cultures and in Mesencephalon E11. By employing gene network techniques, we propose novel models that could explain the transcription regulatory events taking place in the maintenance of the transcriptional identity of the mesencephalon, and in primary cultures derived from this CNS area, with a crucial role in physiology and pathology.

Materials and Methods

Animals and Dissections

Timed pregnant Sprague-Dawley rats (Charles River Breeding Laboratories, Milan, Italy) were sacrificed in accordance with the Society for Neuroscience guidelines and Italian law. Embryonic (E) age was determined by considering the day of insemination (as confirmed by vaginal plug) as day E0. Prenatal brains were quickly removed and placed in phosphate buffered saline (PBS) without calcium and magnesium and supplemented with 33 mM glucose. The ventral midbrain was carefully dissected under a stereoscope in sterile conditions and processed for cell cultures (MesPC) or RNA isolation (MesE11). The use of animals was approved by the Institute of Genetics and Biophysics ethical committee and is in agreement with the European Community Directives. All efforts were made to minimize animal suffering and to reduce the number of animals used.

Cell Cultures

Cells were dissociated from the embryonic rat ventral midbrain and cultured as described [19], [22], [23]. In brief, the tissues were dissected from E11.5 embryos and dissociated using mechanical trituration with a fire polished Pasteur pipette in culture medium (see below) and 0.01% pancreatic deoxyribonuclease (Sigma, Milan, Italy); cells were centrifuged 10 min at 500 g, suspended in Neural Basal Medium (NBM, Invitrogen, Milan, Italy), counted and plated in NBM at a density of 18.000/cm2 in dishes coated with 15 ug/ml of poly-D-Lysine (Sigma). Multiwell plates (Corning Costar, Milan, Italy) were used for all cultures. NBM was supplemented with B27 (Invitrogen, Milan, Italy), fibroblast growth factor 2 (FGF2, 20 ng/ml, Sigma), the N-terminal fragment of Sonic hedgehog protein (SHH, 50 ng/ml) and fibroblast growth factor 8 (FGF8, 10 ng/ml) for 6 days in vitro. SHH was purified as previously described [23]. Half of the medium was changed every three days. After six days the medium supplements were withdrawn with the exception of B27, and was added the ascorbic acid. Cultures were left for an additional three days.

Microarray strategy and sample preparation RNA isolation

To minimize biological variability four pregnant rats were sacrificed and the E11 embryos were mixed obtaining three groups. Each group was treated separately. The ventral midbrains dissected from each group were pooled (MesE11) or dissociated and the cells were cultured in duplicate. After 9 days in vitro the cultures were collected (MesPC). Three microarrays were hybridized with MesE11 and three with MesPC independent samples.

RNA isolation and RT-PCR

RNA obtained from tissues or from primary cultures was extracted using the Tri-Reagent isolation system (Sigma) according to the manufacturer's instructions. The RNA from the culture duplicates was pooled. The yield and integrity of RNA were determined by a spectrophotometer of A260 and agarose gel electrophoresis respectively. Total RNA was treated with a DNA free kit (Ambion Inc., Milan, Italy) to eliminate possible DNA contaminations. For microarray hybridation an additional clean-up of total RNA was performed using the RNeasy kit (Qiagen, Milan, Italy). RNA samples were further processed for microarray hybridization or for RT-PCR. RT-PCR analyses were as previously described [47], [48]. In brief, two ug of RNA were reverse transcribed using random hexanucleotides as primers (New England Biolabs Inc., Milan, Italy, 6 mM) and 200 U of moloney-murine leukemia virus reverse transcriptase (Ambion). 1/20 of the reverse transcribed cDNA was amplified in a 25 ul reaction mixture containing AmpliTaq Gold DNA polymerase buffer (Applied Biosystem, Milan, Italy), 0.2 mM dNTPs (Finnzymes OY, Espoo, Finland), 0.4 mM each primer, 1.25 U AmpliTaq Gold DNA polymerase (Applied Biosystem) and 1 mCi [32P]dCTP (3000 Ci/mmol, Amersham Biosciences, Milan, Italy). As previously described [48], different sets of primer pairs were used in the same reaction tube to co-amplify cDNA, together with primers for the hypoxanthine-phosphoribosyl-transferase (Hprt), a constantly expressed gene during CNS development, used as an internal standard [49]. After a first denaturing step at 95°C for 8 min, PCR amplification was performed for 28 cycles organized as follows: 95°C for 0.5 min; 56°C–58°C for 0.5 min; 72°C for 0.5 min and was followed by a final extension step (72°C for 5 min). The specificity of PCR primers was determined by performing BLAST searches against the databases. Non-reverse-transcribed RNA templates and mock controls were always run in PCR reactions and never gave amplification products. The [32P]-labeled amplified products were separated by electrophoresis in 1.5% agarose gel, dried and exposed to a PhosphorImager screen (Amersham). Quantitation was achieved by integrating the volume areas of each fragment obtained from scanning the screens with PhosphorImager apparatus (Amersham), equipped with ImageQuant software. The ratio between the yield of each amplified product and that of the co-amplified HPRT allowed a relative estimate of the mRNA levels [48]. Triplicate samples allowed statistical analysis.

Probe preparation and microarray hybridization

Using the protocol supplied by the manufacturer (Affymetrix, Santa Clara, CA), double-stranded cDNA was synthesized from total RNA and was used to obtain biotin-labeled cRNA by an in vitro transcription reaction (ENZO Diagnostics, Farmingdale, NY). Biotin-labeled cRNA was fragmented and hybridized with Affymetrix RAE230A rat genome GeneChip microarrays, according to the manufacturer's protocol, after verifying the quality of the biotin-labeled cRNA on a Test Chip (Affymetrix).

Affymetrix probes re-annotation

We used a sequence-based re-annotation of the Affymetrix probes on RAE-230A chipset [28]. The R packages used in this study can be retrieved at http://brainarray.mbni.med.umich.edu/Brainarray/Database/CustomCDF/CDF_download_v10.asp

Data Quality Control

Extensive quality control of the data microarray raw data has been carried out using the methods implemented in the BioConductor packages affy [50] and affyQCReport [51]. All the microarrays showed excellent quality according to the standards, thus all of them were considered for further analysis (data not shown available upon request from the authors).

Data preprocessing

The preprocessing was carried out with the methods implemented in R (http://www.R-project.org) and BioConductor (http://www.bioconductor.org). The CEL files were imported into R environment. After standard quality control (results not shown), the re-annotated data were preprocessed using the RMA algorithm [52]. The RMA allows robust estimation of inter-array variability by employing quantile normalization and by fitting a linear model for each probe set across all the arrays of the dataset.

Feature Selection

The statistical algorithms implemented in the package Limma [53] were employed for selecting the differentially expressed genes. The genes having p-value<0.001 after Benjamini-Hockberg correction [54] were considered as significantly differentially expressed.

Functional analysis

The DAVID gene annotation system was used in order to select over-represented biological terms. Default statistical parameters were employed [27].

Gene network and promoter analysis

For each contrast analyzed, the genes up-regulated in each array group were separately imported into the software Genomatix Bibiosphere to build up gene networks based on their co-citation in the literature as well as the presence of TFBS for known transcription factors in their promoter regions (http://www.genomatix.de/products/BiblioSphere/). The transcription factors (TF) presenting extensive or interesting connectivity within the network were chosen. Consequently, the genes presenting a significant consensus for the selected TFs were further analyzed. The promoter sequences of the genes were retrieved using the software Genomatix Gene2Promoter (http://www.genomatix.de/online help/help eldorado/Gene2Promoter Intro.html) and analyzed with Genomatix FrameWorker (http://www.genomatix.de/online help/help gems/FrameWorker.html) to search for common models containing at least two TFBS. Finally, the significant models were screened for the whole set of known Rattus norvegicus promoters by using Genomatix ModelInspector (http://www.genomatix.de/online help/help fastm/modelinspector help.html).

Statistical analysis

The analyses applied to the microarray data have been described above. For all other experiments, analysis of variance was carried out, followed by post hoc comparison (ANOVA, Scheffè F-test). Data were expressed as mean+/−SEM. Summary of the PCR validations of the microarray results:The Nr4a2, Th, and Egr1 gene expression have been tested by PCR and statistically validated as described in materials and methods. (0.04 MB TIF) Click here for additional data file. Genes significant in the three analyses with a DAVID annotation. Fields: DAVIDID: DAVID unique ID; EG: Entrez Gene ID; logFC_EG: logarithmic fold change (MesPC-MesE11) based on the EG re-annotation; P.Value_EG: p-value based on the EG re-annotation; adj.P.Val_EG: adjusted (Benjamini-Hochberg) p-value based on the EG re-annotation; ENSID: Ensembl gene ID; logFC_ENS: logarithmic fold change (MesPC-MesE11) based on the ENS re-annotation; P.Value_ENS: p-value based on the ENS re-annotation; adj.P.Val_ENS: adjusted (Benjamini-Hochberg) p-value based on the ENS re-annotation; RSID: RefSeq ID; logFC_RS: logarithmic fold change (MesPC-MesE11) based on the RS re-annotation; P.Value_RS: p-value based on the RS re-annotation; adj.P.Val_RS: adjusted (Benjamini-Hochberg) p-value based on the RS re-annotation; GeneName: official gene name. (0.15 MB XLS) Click here for additional data file. Functional analysis of the genes significantly over-expressed in MesPC. Each stack represents a group of related functional terms. Each term within each stack is in a row of the table. The number of genes annotated, the percent of representation of the term, and the enrichment p-value are shown. (0.29 MB XLS) Click here for additional data file. Summary of the Genomatix ModelInspector analysis for V$EGR-V$SP1F. Rattus norvegicus promoter sequences showing the V$EGR-V$SP1F module. For each match, the sequence annotation, the position of the module, and the strand are indicated. Over-represented Geneontology terms are also shown starting from page 53. (0.39 MB PDF) Click here for additional data file. Functional analysis of the genes significantly over-expressed in MesE11. Each stack represents a group of related functional terms. Each term within each stack is in a row of the table. The number of genes annotated, the percent of representation of the term, and the enrichment p-value are shown. (0.19 MB XLS) Click here for additional data file. Summary of the Genomatix ModelInspector analysis for V$NEUR-V$NR2F. Rattus norvegicus promoter sequences showing the V$NEUR-V$NR2F module. For each match, the sequence annotation, the position of the module, and the strand are indicated. Over-represented Geneontology terms are also shown starting from page 57. (0.35 MB PDF) Click here for additional data file.
  50 in total

Review 1.  Chemical neuroanatomy of the basal ganglia--normal and in Parkinson's disease.

Authors:  O Hornykiewicz
Journal:  J Chem Neuroanat       Date:  2001-07       Impact factor: 3.052

Review 2.  Inherited movement disorders.

Authors:  Nutan Sharma; David G Standaert
Journal:  Neurol Clin       Date:  2002-08       Impact factor: 3.806

3.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data.

Authors:  Rafael A Irizarry; Bridget Hobbs; Francois Collin; Yasmin D Beazer-Barclay; Kristen J Antonellis; Uwe Scherf; Terence P Speed
Journal:  Biostatistics       Date:  2003-04       Impact factor: 5.899

4.  affy--analysis of Affymetrix GeneChip data at the probe level.

Authors:  Laurent Gautier; Leslie Cope; Benjamin M Bolstad; Rafael A Irizarry
Journal:  Bioinformatics       Date:  2004-02-12       Impact factor: 6.937

Review 5.  Molecular mechanisms controlling the development of dopaminergic neurons.

Authors:  John C Lin; Arnon Rosenthal
Journal:  Semin Cell Dev Biol       Date:  2003-06       Impact factor: 7.727

6.  In vitro maturation of mesencephalic dopaminergic neurons from mouse embryos is enhanced in presence of their striatal target cells.

Authors:  A Prochiantz; U di Porzio; A Kato; B Berger; J Glowinski
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

7.  Modulation of nurr1 gene expression in mesencephalic dopaminergic neurones.

Authors:  Floriana Volpicelli; Carla Perrone-Capano; Paola Da Pozzo; Luca Colucci-D'Amato; Umberto di Porzio
Journal:  J Neurochem       Date:  2004-03       Impact factor: 5.372

8.  Effect of striatal cells on in vitro maturation of mesencephalic dopaminergic neurones grown in serum-free conditions.

Authors:  U di Porzio; M C Daguet; J Glowinski; A Prochiantz
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

9.  Involvement of Nurr1 in specifying the neurotransmitter identity of ventral midbrain dopaminergic neurons.

Authors:  Simone M Smits; Tiia Ponnio; Orla M Conneely; J Peter H Burbach; Marten P Smidt
Journal:  Eur J Neurosci       Date:  2003-10       Impact factor: 3.386

10.  Enhancement of dopaminergic differentiation in proliferating midbrain neuroblasts by sonic hedgehog and ascorbic acid.

Authors:  Floriana Volpicelli; Claudia Consales; Massimiliano Caiazzo; Luca Colucci-D'Amato; Carla Perrone-Capano; Umberto di Porzio
Journal:  Neural Plast       Date:  2004       Impact factor: 3.599

View more
  8 in total

1.  Neuronal development genes are key elements mediating the reinforcing effects of methamphetamine, amphetamine, and methylphenidate.

Authors:  Ike Dela Peña; Se Jin Jeon; Eunyoung Lee; Jong Hoon Ryu; Chan Young Shin; Minsoo Noh; Jae Hoon Cheong
Journal:  Psychopharmacology (Berl)       Date:  2013-06-20       Impact factor: 4.530

2.  Functional reduction of SK3-mediated currents precedes AMPA-receptor-mediated excitotoxicity in dopaminergic neurons.

Authors:  Bruno A Benítez; Helen M Belálcazar; Agustín Anastasía; Daniel T Mamah; Charles F Zorumski; Daniel H Mascó; Daniel G Herrera; Gabriel A de Erausquin
Journal:  Neuropharmacology       Date:  2010-10-31       Impact factor: 5.250

3.  Gene expression analysis in SV-40 immortalized human corneal epithelial cells cultured with an air-liquid interface.

Authors:  Dario Greco; Kati-Sisko Vellonen; Helen C Turner; Marika Häkli; Timo Tervo; Petri Auvinen; J Mario Wolosin; Arto Urtti
Journal:  Mol Vis       Date:  2010-10-15       Impact factor: 2.367

4.  ParkDB: a Parkinson's disease gene expression database.

Authors:  Cristian Taccioli; Jesper Tegnér; Vincenza Maselli; David Gomez-Cabrero; Gioia Altobelli; Warren Emmett; Francesco Lescai; Stefano Gustincich; Elia Stupka
Journal:  Database (Oxford)       Date:  2011-05-18       Impact factor: 3.451

5.  Neuronal differentiation dictates estrogen-dependent survival and ERK1/2 kinetic by means of caveolin-1.

Authors:  Floriana Volpicelli; Massimiliano Caiazzo; Bruno Moncharmont; Umberto di Porzio; Luca Colucci-D'Amato
Journal:  PLoS One       Date:  2014-10-28       Impact factor: 3.240

Review 6.  Dopamine: The Neuromodulator of Long-Term Synaptic Plasticity, Reward and Movement Control.

Authors:  Luisa Speranza; Umberto di Porzio; Davide Viggiano; Antonio de Donato; Floriana Volpicelli
Journal:  Cells       Date:  2021-03-26       Impact factor: 6.600

7.  Anti-schistosomal intervention targets identified by lifecycle transcriptomic analyses.

Authors:  Jennifer M Fitzpatrick; Emily Peak; Samirah Perally; Iain W Chalmers; John Barrett; Timothy P Yoshino; Alasdair C Ivens; Karl F Hoffmann
Journal:  PLoS Negl Trop Dis       Date:  2009-11-03

8.  Effects of Mecp2 loss of function in embryonic cortical neurons: a bioinformatics strategy to sort out non-neuronal cells variability from transcriptome profiling.

Authors:  Marcella Vacca; Kumar Parijat Tripathi; Luisa Speranza; Riccardo Aiese Cigliano; Francesco Scalabrì; Federico Marracino; Michele Madonna; Walter Sanseverino; Carla Perrone-Capano; Mario Rosario Guarracino; Maurizio D'Esposito
Journal:  BMC Bioinformatics       Date:  2016-01-20       Impact factor: 3.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.